Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.38 |
| ▸ | SCN1A | P35498 | 2/20 | 0.33 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.33 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23519039 | 0.81 | NOTUM (0.45) | NOTUMCYP19A1 | |
| SCHEMBL23518975 | 0.81 | SCN1A (0.31) | NOTUMSCN1ASCN2ASCN3A | |
| SCHEMBL23518947 | 0.80 | NOTUM (0.53) | NOTUM | |
| SCHEMBL23518950 | 0.77 | NOTUM (0.41) | NOTUM | |
| SCHEMBL24361197 | 0.75 | SCN8A (0.38) | NOTUM | |
| SCHEMBL23518968 | 0.74 | GABRA1 (0.42) | NOTUM | |
| SCHEMBL23518972 | 0.73 | ADORA3 (0.40) | NOTUMCYP19A1 | |
| SCHEMBL23519131 | 0.66 | SLC6A4 (0.42) | NOTUMFFAR4 | |
| SCHEMBL23383176 | 0.66 | SCN1A (0.43) | SCN1ASCN2ASCN3ACYP19A1FFAR4 | |
| SCHEMBL3411398 | 0.66 | SCN1A (0.54) | SCN1ASCN2ASCN3ACYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210179554-A1 | ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210179554-A1 | ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SLC6A5, LIFR, SLC6A9 | NOTUM 576/4885SCN1A 774/4885SCN2A 984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.